ORIGENE TALISMA-S CAPSULE 250MG
ORIGENE TALISMA-S CAPSULE 250MG : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.
NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.
Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0
The foreign register category does not determine the regulatory category of the product in France.
French and European references for recognised ingredients
- Conditions légales
Nigella sativa L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les enfants, adolescents, femmes enceintes ou allaitantes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.
Published composition
| Published ingredient | Published text and quantity | Identified nutrient or substance |
|---|---|---|
| Allium cepa | Allium cepa[30mg;250mg] | Not identified |
| Nigella sativa | Nigella sativa[30mg;250mg] | Not identified |
| Cuminum cyminum | Cuminum cyminum[30mg;250mg] | Not identified |
| Zingiber officinale | Zingiber officinale[35mg;250mg] | Not identified |
| Eugenia caryophyllata | Eugenia caryophyllata[30mg;250mg] | Not identified |
| Coffea arabica | Coffea arabica[30mg;250mg] | Not identified |
| Anethum graveolens | Anethum graveolens[35mg;250mg] | Not identified |
| Allium sativum | Allium sativum[30mg;250mg] | Not identified |
The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.
Product record
- Registration number
- MAL12105047TC
- Type
- Natural product
- Published status
- PRODUCT APPROVED
- Licence holder
- DIMECARE MANAGEMENT & SERVICES
- Manufacturer
- SARI TANI DESA SDN. BHD.
- Registration period starting
- 2023-08-31
- Published validity end
- 2028-08-31
Original register data
View published fields and their variants
- Active ingredients
- Allium cepa[30mg;250mg],Nigella sativa[30mg;250mg],Cuminum cyminum[30mg;250mg],Zingiber officinale[35mg;250mg],Eugenia caryophyllata[30mg;250mg],Coffea arabica[30mg;250mg],Anethum graveolens[35mg;250mg],Allium sativum[30mg;250mg]
- Valid until
- 2028-08-31
- Registration date
- 2023-08-31
- Published description
- NATURAL PRODUCT
- Licence holder
- DIMECARE MANAGEMENT & SERVICES
- Producer
- SARI TANI DESA SDN. BHD.
- Published name
- ORIGENE TALISMA-S CAPSULE 250MG
- Published reference
- 201110042014T
- Registration number
- MAL12105047TC
- Published status
- PRODUCT APPROVED
Official source
View the official register, number MAL12105047TC
Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Zingiber officinale
Read the warning, when it applies and the studies cited
GINGER - ZINGIBER OFFICINALE
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
- Coffea arabica
Read the warning, when it applies and the studies cited
GREEN COFFEE BEAN EXTRACT
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding.
Contraindications
Do not use if you are pregnant.
- Allium sativum
Read the warning, when it applies and the studies cited
Garlic - Allium sativum
Route of administration: Oral
Cautions and warnings
Condition of application: Relief of upper respiratory tract infections and catarrhal (nasal congestion) conditions.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Condition of application: All uses.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners or protease inhibitors (Brinker 2010; Mills and Bone 2005).
Sources cited by Health Canada (2)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant (Brinker 2010; Mills and Bone 2005).
Sources cited by Health Canada (2)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes (Brinker 2010; Mills and Bone 2005).
Sources cited by Health Canada (2)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
Known adverse reactions
Stop use if hypersensitivity/allergy occurs (Brinker 2010; Mills and Bone 2005).
Sources cited by Health Canada (2)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “ORIGENE TALISMA-S CAPSULE 250MG”, https://compoatlas.com/en/supplements/malaysia/MAL12105047TC-origene-talisma-s-capsule-250mg, updated 27 October 2026.